101. Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
- Author
-
Mona Kilany, Hamed A. Ghramh, and Essam H. Ibrahim
- Subjects
Science (General) ,02 engineering and technology ,010501 environmental sciences ,01 natural sciences ,EIA, Enzyme immunoassay ,Serology ,law.invention ,Q1-390 ,law ,HBV, Hepatitis B virus ,SD, Standard deviations ,ORFs, Open reading frames ,Nucleocapsid protein ,Multidisciplinary ,medicine.diagnostic_test ,HTLV, Human T-lymphotropic virus ,Covid-19, Coronavirus Disease-2019 ,TMB, 3,3′,5,5′-Tetramethylbenzidine ,021001 nanoscience & nanotechnology ,N, Nucleocapsid protein ,Reverse transcription polymerase chain reaction ,HIV, Human immunodeficiency virus ,Recombinant DNA ,Original Article ,ELISA ,Antibody ,0210 nano-technology ,Covid-19 ,ELISA, Enzyme-linked immunosorbant assay ,ROC, Receiver operating characteristic ,CoVs, Coronaviruses ,Biology ,Spike protein ,Virus ,HCV, Hepatitis C virus ,BSA, Bovine serum albumin ,S, Spike protein ,medicine ,CMV, Cytomegalovirus ,0105 earth and related environmental sciences ,SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 ,Receiver operating characteristic ,SARS-CoV-2 ,RT-PCR, Reverse transcription polymerase chain reaction ,Gold standard (test) ,AUC, Area under the curve ,M, Membrane protein ,Virology ,E, Envelope protein ,Immunoassay ,RBD, Receptor-binding domain ,biology.protein ,OD, Optical density - Abstract
By the end of year 2019, the new virus SARS-CoV-2 appeared, causing the Coronavirus Disease 2019 (COVID-19), and spread very fast globally. A continuing need for diagnostic tools is a must to contain its spread. Till now, the gold standard method, the reverse transcription polymerase chain reaction (RT-PCR), is the precise procedure to detect the virus. However, SARS-CoV-2 may escape RT-PCR detection for several reasons. The development of well-designed, specific and sensitive serological test like enzyme immunoassay (EIA) is needed. This EIA can stand alone or work side by side with RT-PCR. In this study, we developed several EIAs including plates that are coated with either specially designed SARS-CoV-2 nucleocapsid or surface recombinant proteins. Each protein type can separately detect anti-SARS-CoV-2 IgM or IgG antibodies. For each EIAs, the cut-off value, specificity and sensitivity were determined utilizing RT-PCR confirmed Covid-19 and pre-pandemic healthy and other viruses-infected sera. Also, the receiver operator characteristic (ROC) analysis was performed to define the specificities and sensitivities of the optimized assay. The in-house EIAs were validated by comparing against commercial EIA kits. All in-house EIAs showed high specificity (98–99%) and sensitivity (97.8–98.9%) for the detection of IgG/IgM against RBD and N proteins of SARS-CoV-2. From these results, the developed Anti-RBD and anti-N IgG and IgM antibodies EIAs can be used as a specific and sensitive tool to detect SARS-CoV-2 infection, calculate the burden of disease and case fatality rates.
- Published
- 2021